These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9802625)

  • 21. A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide--CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge phase.
    Riddell A; Buttery JP; McVernon J; Chantler T; Lane L; Bowen-Morris J; Diggle L; Morris R; Lockhart S; Pollard AJ; Cartwright K; Moxon ER
    Vaccine; 2007 May; 25(19):3906-12. PubMed ID: 17368663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
    Perrett KP; Snape MD; Ford KJ; John TM; Yu LM; Langley JM; McNeil S; Dull PM; Ceddia F; Anemona A; Halperin SA; Dobson S; Pollard AJ
    Pediatr Infect Dis J; 2009 Mar; 28(3):186-93. PubMed ID: 19209097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of meningococcal serogroup C-specific antibody levels in British Columbian children and adolescents.
    Mitchell LA; Ochnio JJ; Glover C; Lee AY; Ho MK; Bell A
    J Infect Dis; 1996 Apr; 173(4):1009-13. PubMed ID: 8603941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants.
    Rennels M; King J; Ryall R; Papa T; Froeschle J
    Pediatr Infect Dis J; 2004 May; 23(5):429-35. PubMed ID: 15131466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence, serogroup distribution and risk factors of meningococcal carriage in adolescents and young adults in Turkey.
    Tekin RT; Dinleyici EC; Ceyhan M; Karbuz A; Salman N; Sutçu M; Kurugol Z; Balliel Y; Celik M; Hacimustafaoglu M; Kuyucu N; Kondolot M; Sensoy G; Metin O; Kara SS; Dinleyici M; Kılıç O; Bayhan C; Gurbuz V; Aycan E; Memedova A; Karli A; Bozlu G; Celebi S
    Hum Vaccin Immunother; 2017 May; 13(5):1182-1189. PubMed ID: 28140784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected children.
    Siberry GK; Warshaw MG; Williams PL; Spector SA; Decker MD; Jean-Philippe P; Yogev R; Heckman BE; Manzella A; Roa J; Nachman S; Lujan-Zilbermann J;
    Pediatr Infect Dis J; 2012 Jan; 31(1):47-52. PubMed ID: 21987006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective activity of group C anticapsular antibodies elicited in two-year-olds by an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine.
    Granoff DM; Harris SL
    Pediatr Infect Dis J; 2004 Jun; 23(6):490-7. PubMed ID: 15194828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between serum bactericidal activity and serogroup-specific immunoglobulin G concentration for adults, toddlers, and infants immunized with Neisseria meningitidis serogroup C vaccines.
    Sikkema DJ; Friedman KE; Corsaro B; Kimura A; Hildreth SW; Madore DV; Quataert SA
    Clin Diagn Lab Immunol; 2000 Sep; 7(5):764-8. PubMed ID: 10973451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants.
    Rennels MB; Edwards KM; Keyserling HL; Reisinger K; Blatter MM; Quataert SA; Madore DV; Chang I; Malinoski FJ; Hackell JG; Paradiso PR
    Pediatr Infect Dis J; 2001 Feb; 20(2):153-9. PubMed ID: 11224833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine.
    Kristiansen PA; Diomandé F; Wei SC; Ouédraogo R; Sangaré L; Sanou I; Kandolo D; Kaboré P; Clark TA; Ouédraogo AS; Absatou KB; Ouédraogo CD; Hassan-King M; Thomas JD; Hatcher C; Djingarey M; Messonnier N; Préziosi MP; LaForce M; Caugant DA
    Clin Vaccine Immunol; 2011 Mar; 18(3):435-43. PubMed ID: 21228139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and immunogenicity of meningococcus serogroup C conjugate vaccine administered as a primary or booster vaccination to healthy four-year-old children.
    McVernon J; Maclennan J; Buttery J; Oster P; Danzig L; Moxon ER
    Pediatr Infect Dis J; 2002 Aug; 21(8):747-53. PubMed ID: 12192163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limited Impact of Adolescent Meningococcal ACWY Vaccination on Neisseria meningitidis Serogroup W Carriage in University Students.
    Oldfield NJ; Green LR; Parkhill J; Bayliss CD; Turner DPJ
    J Infect Dis; 2018 Jan; 217(4):608-616. PubMed ID: 29155998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger.
    Campagne G; Garba A; Fabre P; Schuchat A; Ryall R; Boulanger D; Bybel M; Carlone G; Briantais P; Ivanoff B; Xerri B; Chippaux JP
    Pediatr Infect Dis J; 2000 Feb; 19(2):144-50. PubMed ID: 10694002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of a serogroup B meningococcal vaccine against multiple Neisseria meningitidis strains in infants.
    Morley SL; Cole MJ; Ison CA; Camaraza MA; Sotolongo F; Anwar N; Cuevas I; Carbonero M; Campa HC; Sierra G; Levin M
    Pediatr Infect Dis J; 2001 Nov; 20(11):1054-61. PubMed ID: 11734711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.
    Snape MD; Perrett KP; Ford KJ; John TM; Pace D; Yu LM; Langley JM; McNeil S; Dull PM; Ceddia F; Anemona A; Halperin SA; Dobson S; Pollard AJ
    JAMA; 2008 Jan; 299(2):173-84. PubMed ID: 18182599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meningococcal group C and w135 immunological hyporesponsiveness in african toddlers.
    Findlow H; Sow S; Borrow R; Tapia M; Haidara FC; Akinsola AK; Idoko OT; Diallo F; Adegbola R; Tang Y; Parulekar V; Chadha H; Mabey L; Holme D; Townsend K; Chaumont J; Laforce FM; Kulkarni PS; Marchetti E; Viviani S; Hassan-King M; Preziosi MP
    Clin Vaccine Immunol; 2011 Sep; 18(9):1492-6. PubMed ID: 21752951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospects for vaccine prevention of meningococcal infection.
    Harrison LH
    Clin Microbiol Rev; 2006 Jan; 19(1):142-64. PubMed ID: 16418528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody responses to serogroup B meningococcal outer membrane antigens after vaccination and infection.
    Rosenqvist E; Harthug S; Frøholm LO; Høiby EA; Bøvre K; Zollinger WD
    J Clin Microbiol; 1988 Aug; 26(8):1543-8. PubMed ID: 3139705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single-dose antihelminthic treatment does not influence immunogenicity of a meningococcal and a cholera vaccine in Gabonese school children.
    Brückner S; Agnandji ST; Elias J; Berberich S; Bache E; Fernandes J; Loembe MM; Hass J; Lell B; Mordmüller B; Adegnika AA; Kremsner P; Esen M
    Vaccine; 2016 Oct; 34(44):5384-5390. PubMed ID: 27642131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody responses to the capsular polysaccharide of Neisseria meningitidis serogroup B in patients with meningococcal disease.
    Granoff DM; Kelsey SK; Bijlmer HA; Van Alphen L; Dankert J; Mandrell RE; Azmi FH; Scholten RJ
    Clin Diagn Lab Immunol; 1995 Sep; 2(5):574-82. PubMed ID: 8548537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.